HOPA26
HOPA 2026: Best Practices for Clinical Trials Across the Enterprise
Drs. Elyse MacDonald and Jennifer Murphy provide implementation strategies and best practices to navigate a ...
APRIL 7, 2026
Happy National Oncology Pharmacists Day!
In honor of the inaugural National Oncology Pharmacists Day, PPN caught up with some HOPA attendees to ask how does ...
APRIL 3, 2026
HOPA 2026: 340B Drug Pricing Program Updates
Dr. Anthony Trovato provides an overview of the recent and ongoing updates to the 340B Drug Pricing Program, what ...
MARCH 31, 2026
Biosimilar Uptake Surges After Order Set Change at Academic Infusion Center
Biosimilar adoption study shows switching default oncology order sets to formulary biosimilars greatly increased ...
MARCH 30, 2026
A Synergy of CAR-T Hematotoxicity Scoring Tools
Cytopenia prediction strategies using CAR-HEMATOTOX and KyoTox show phase-specific strengths that aid precision ...
MARCH 30, 2026
4 Targeted Agents in 5 Years: BRAF/MEK Inhibitors Are Transforming Pediatric Oncology Pharmacy
Pediatric oncology pharmacists gain new targeted therapies for BRAF-altered tumors, improving outcomes and ...
MARCH 27, 2026
Gut Check: Gastric and Esophageal Cancer Treatment Evolves
Zolbetuximab for gastric and esophageal cancer improves survival but requires careful antiemetic management to ...
MARCH 27, 2026
GLP-1s in Oncology: Mixed Evidence and Shared Decision-Making
The evidence behind a boxed warning for thyroid cancer that has made many oncology clinicians wary of GLP-1 ...
MARCH 27, 2026
HOPA 2026: Role of GLP-1s in Oncology
Drs. Colleen McCabe and Lindsay Mundy discuss both the potential risks and benefits of GLP-1s for patients actively ...
MARCH 27, 2026
Wicked Hot: Theranostics in Oncology Pharmacy
Theranostic radiopharmaceuticals unite nuclear and oncology pharmacy, driving collaboration, training, and access ...
MARCH 26, 2026
Medicaid Cuts, Federal Policy Shifts Threaten 340B Eligibility for Safety-Net Hospitals
Drug pricing changes reduce hospital support as shifting Medicaid rules shrink program access nationwide.
MARCH 26, 2026
Survey Shows Wide Variation, Significant Gaps in Oncology Pharmacy Residency Leadership
Cancer pharmacology programs reveal leadership strain and uneven support for preceptors guiding advanced clinical ...
MARCH 26, 2026
